CDK1 triggers the initiation of cytokinesis by inducing the nuclear localization of mitotic cyclins A and B (Pesin and Orr-Weaver, 2008), and its inhibition has been proposed as a cancer therapy with potentially higher efficacy than the inactivation of other CDKs (Diril et al., 2012). This evidence concerns the gene CDK1 and cancer.